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A case of stomach cancer metastatic to the 
uterine cervix
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Signet-ring cell carcinoma presenting in the uterine cervix is rare. Although the incidence is rare, the gastrointestinal tract 
should be considered as a possible primary site of metastatic uterine cervical cancer. We experienced a patient who under-
went radical subtotal gastrectomy with right hemicolectomy and adjuvant chemotherapy due to gastric cancer and sub-
sequently suffered from recurrence at the uterine cervix. Laparoscopic radical hysterectomy with bilateral salpingo-oopho-
rectomy with pelvic lymph node dissection was performed. We report a case of the stomach cancer metastatic to the uterine 
cervix. 
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Introduction
Metastatic uterine cervical carcinomas are generally 
originated from intrapelvic organs. However, the meta-
stases from extrapelvic organs are rare.1-6 Kumar and 
Hart7 demonstrated that uterine cervical carcinomas arise 
primary in the breast (42.9%), colon (17.5%), stomach 
(11.1%), pancreas (11.1%), gallbladder (4.8%), lung (4.8%), 
cutaneous melanoma (3.2%), urinary bladder (3.2%), and 
thyroid (1.6%). Among these, it is a rare case that ute-
rine cervical cancer is caused and spread from stomach 
cancer not only in Asian countries, but also in the 
Western countries. In spite of rare case, it is important 
to consider a relationship between metastatic cervical can-
cer and primary stomach cancer because the incidence of 
these cancers is relatively high in Asian, including Korea 
and Japan.
Herein, we report a case of a 32-year-old woman who 
underwent radical subtotal gastrectomy with right hemi-
colectomy and adjuvant chemotherapy due to stomach 
cancer and then suffered from recurrence at the uterine 
cervix. 
Case Report
Patient was a 32-year-old woman who underwent radi-
cal subtotal gastrectomy (Billroth I) and right hemicolectomy 
due to stomach cancer at April 2006. At that time, the 
pathologic result showed stage II stomach cancer (T3N0M0) 
and 7.5×6.8×2.3 cm sized Borrmann (unclassified)-type 
mass was observed at lower 1/3 of antrum and central 
part of posterior wall of the stomach. Histological type 
was tubular adenocarcinoma with poor differentiation and 
a diffuse type according to the Lauren's classification. 
There was no lymph nodes metastasis. The patient un-
derwent 9 cycles of combination chemotherapy of irino-
tecan, 5-FU and leucovorin as a postoperative adjuvant 
therapy from May 2006 to November 2006 and has been 
followed up.
The patient visited our institution in March 2009 due 
to vaginal bleeding and lower abdominal discomfort for 
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Fig. 1. (A) Magnetic resonance im-
age shows that a mass is located in 
the uterine cervix with parametrial 
invasion. (B) F-18 flurodeoxyglucose
(FDG) positron emission tomog-
raphy/computed tomography shows
that there is increased FDG uptake 
in the cervical mass, consistent with 
malignancy. 
Fig. 2. The gross appearance of the resected uterus with para-
metrial tissue. 
2 months. She did not experience loss of weight or men-
strual irregularity in the previous 6 months. She had 
family history of hypertension and cerebral stroke. On 
the pelvic examination, the uterus was antroversioned, 
and a hard and movable mass was palpable at posterior part 
of the uterine cervix. Result of Pap smear showed 
adenocarcinoma. The result of biopsy at the exocervix 
and endocervix was metastatic adenocarcioma, with part-
ly signet ring cell feature, clinically from the stomach. 
Magnetic resonance imaging and F-18 flurodeoxyglucose 
(FDG) positron emission tomography/computed tomog-
raphy also showed a 3.0×2.4 cm mass in the central part 
of the uterine cervix with suspicious parametrial in-
vasion and increased FDG uptake (Fig. 1). Serum carci-
noembryonic antigen level was 1.19 ng/mL and squ-
amous cell carcinoma antigen (SCC Ag) level was 0.7 
ng/mL. Serum CA19-9 and CA-125 level was 1680.0 U/mL 
and 13.5 U/mL, respectively. Based on results of these 
imaging studies and pelvic examination, the patient was 
diagnosed as metastatic cervical cancer from stomach 
cancer. Therefore, laparoscopic radical hysterectomy 
with bilateral salpingo-oophorectomy and pelvic lymph 
node dissection was performed. The final pathologic di-
agnosis was metastatic adenocarcioma, with partly signet 
ring cell feature, involving endocervix from pericervical 
soft tissue to mucosa, clinically from the stomach. The patient 
discharged on postoperative day 6 without complication. 
At 3 weeks after surgery, she underwent postoperative 
adjuvant chemotherapy in oncology with TS-1/CDDP 
(gemeracil 7.25 mg, oteracil potassium 19.6 mg, tegafur 
25 mg, cisplatin 85 mg) in three week intervals and re-
ceived 2 cycles. After chemotherapy, the patient wanted 
to stop treatment and then was lost to follwed up in out-
patient clinic.
Patholohistologic findings
The serous surface of uterus was smooth and its 
weight and size was 189 g and 11×5×4 cm, respectively. 
The thickness of endometrium was 2 cm and 4×2 cm 
sized round mass invaded serosa. About a 2×1 cm mass 
protruding to uterine cervix was observed (Fig. 2). No 
histology showing tumor cells were observed in either 
the ovaries or the fallopian tubes. Tumor cells were not 
observed at intraperitoneal cytology evaluation. The im-
munohistochemical analysis of the specimens was performed. 
The left parametrial tissue, presenting with a few atypical 
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Fig. 3. Microscopic findings of metastatic adenocarcinoma with signet ring cell feature. (A) H&E, ×100. (B) H&E, ×400.
cells, were diffusely positive for cytokeratin AE1-AE3, 
carcinoembryonic antigen (Fig. 3). 
Discussion
It is common that intrapelvic organ-originated carcinomas 
are metastasized to uterus. However, it is rare that extrapelvic 
organ-originated malignant carcinomas are metastasized 
secondly to the uterus.1-6 Additionally, uterine cervical 
adenocarcinoma occupies 15-20% of all the uterine cer-
vical cancer and its majority is the endocervix-originated 
adenocarcinoma.6,8,9 Of these, metastatic cervical cancer 
with signet-ring cell feature is extremely rare; when found, 
it nearly always represents a metastasis, usually from the 
stomach and rarely from colon, ovary, breast, and lung.4 
The metastases to uterine cervix are often transmitted by 
lymphovascular system. In this case, we suspected primary 
gastrointestinal tract carcinoma was reversely transmitted 
by lymphatic system as an unusual occurrence. It’s rare 
incidence can be explained as follows. The uterine cer-
vix is composed of fibrin tissues unfavorable for growth 
of metastatic cells. In case of relatively small and less 
vascularized status, pelvic lymphovascular system flows 
away from uterine cervix. Moreover, when diagnosed as 
uterine cervical adenocarcinoma, it is difficult to suspect 
and diagnose that the carcinoma was metastasized from 
another site. Because women with adenocarcinoma of 
breast or gastrointestinal tract can be neglected in ute-
rine cervical examination, an evaluation of the uterine 
cervix, such as cervical biopsy, is not properly con-
ducted and the metastasis cannot be diagnosed at time. 
Stemmermann5 recommended that uterine metastasis al-
ways had to be considered when patients experienced 
abnormal vaginal bleeding with a history of diagnosis and 
treatment of primary extrapelvic-originated carcinoma.3,10 
Suarez-Penaranda et al.6 reported two cases that patients 
with stomach cancer had abnormal vaginal bleeding and 
metastases to the uterine cervix were found after uterine 
cervical biopsy. Similarly, we experienced a case of a 
32-year-old woman who gradually underwent irregular 
menstruation cycles, menorrhagia and lower abdominal 
pain after treatment for stomach cancer and was histo-
logically proven intrauterine exclusive metastatic ad-
enocarcinoma with partly signet ring cell feature, clinically 
from the stomach. Treatment of metastatic adenocarcinoma 
of the cervix does not differ from one of recurrent cer-
vical cancer. The salvage therapy with chemotherapy is 
used mainly and the prognosis of patients is very poor 
regardless of the hysterectomy. Imachi et al.1 reported 
uterine cervical metastasis in gastric cancer patients 
treated with cisplatin-based chemotherapy, but there was 
no improved survival outcome. 
In conclusion, metastatic cancer to the uterine cervix 
always has to be considered when patient experiences 
abnormal vaginal bleeding with a history of primary 
gastrointestinal tract carcinoma. In addition, patient who 
diagnosed as metastatic cervical cancer needs to fully 
evaluate the existence of primary extrapelvic-originated 
carcinoma, including stomach, though the incidence is 
rare.
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